Three-Dimensional Visualization With Tissue Clearing Uncovers Dynamic Alterations of Renal Resident Mononuclear

Kipyo Kim1, Yun-Gyeong Kim2, Su Woong Jung2

  • 1Division of Nephrology and Hypertension, Department of Internal Medicine, Inha University School of Medicine, Incheon, South Korea.

Insights

Optical tissue clearing with advanced microscopy reveals dynamic changes in immune cells during acute kidney injury (AKI). This study shows NLRP3 inhibition improves kidney function by reducing immune cell activation in AKI.

Area of Science:

  • Nephrology
  • Immunology
  • Microscopy

Background:

  • Traditional histology struggles to capture dynamic immune cell changes in acute kidney injury (AKI).
  • Optical tissue clearing combined with multiphoton microscopy (MPM) or light sheet fluorescence microscopy (LSFM) offers advanced deep tissue visualization.
  • These techniques enhance understanding of immune cell dynamics during tissue injury and repair.

Purpose of the Study:

  • To investigate morphological and functional alterations of renal mononuclear phagocytes (MNPs) in lipopolysaccharide (LPS)-induced AKI.
  • To evaluate the effect of the NLRP3 inhibitor MCC950 on CD11c+ cell activation in LPS-induced AKI.
  • To utilize renal clearing and advanced microscopy for 3D visualization of immune cell changes in AKI.

Main Methods:

  • Utilized CD11c-YFP mice for studying renal mononuclear phagocytes (MNPs).
  • Employed optical tissue clearing techniques for whole mouse kidney imaging.
  • Performed deep tissue imaging using light sheet fluorescence microscopy (LSFM) and multiphoton microscopy (MPM).
  • Assessed immune cell activation markers (MHC class II, CD86) and renal function.

Main Results:

  • LPS-induced AKI significantly increased CD11c+ cell numbers and density, particularly in periglomerular and perivascular areas.
  • High-resolution MPM revealed morphological changes in CD11c+ cells, including increased dendrites.
  • Activated CD11c+ cells showed increased MHC class II and CD86 expression.
  • Treatment with NLRP3 inhibitor MCC950 attenuated CD11c+ cell activation and improved renal function.

Conclusions:

  • 3D visualization techniques (MPM, LSFM) combined with kidney clearing effectively reveal dynamic changes in renal MNPs during AKI.
  • These dynamic immune cell alterations are directly linked to renal function.
  • NLRP3 inhibition represents a potential therapeutic strategy for AKI by modulating immune cell activation.

Related Concept Videos